Works matching IS 14611457 AND DT 2022 AND VI 25 AND IP 2

Results: 8
    1
    2
    3
    4
    5

    Choice of Either Quetiapine or Aripiprazole as Augmentation Treatment in a European Naturalistic Sample of Patients With Major Depressive Disorder.

    Published in:
    International Journal of Neuropsychopharmacology, 2022, v. 25, n. 2, p. 118, doi. 10.1093/ijnp/pyab066
    By:
    • Bartova, Lucie;
    • Fugger, Gernot;
    • Dold, Markus;
    • Kautzky, Alexander;
    • Swoboda, Marleen Margret Mignon;
    • Rujescu, Dan;
    • Zohar, Joseph;
    • Souery, Daniel;
    • Mendlewicz, Julien;
    • Montgomery, Stuart;
    • Fabbri, Chiara;
    • Serretti, Alessandro;
    • Kasper, Siegfried
    Publication type:
    Article
    6
    7

    Evaluation of the Safety, Tolerability, and Pharmacokinetic Profiles of TP0473292 (TS-161), A Prodrug of a Novel Orthosteric mGlu2/3 Receptor Antagonist TP0178894, in Healthy Subjects and Its Antidepressant-Like Effects in Rodents.

    Published in:
    International Journal of Neuropsychopharmacology, 2022, v. 25, n. 2, p. 106, doi. 10.1093/ijnp/pyab062
    By:
    • Watanabe, Mai;
    • Marcy, Brian;
    • Hiroki, Ayano;
    • Watase, Hirotaka;
    • Kinoshita, Kohnosuke;
    • Iijima, Michihiko;
    • Marumo, Toshiyuki;
    • Zarate, Carlos A;
    • Chaki, Shigeyuki
    Publication type:
    Article
    8